![Kevin H. Sills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin H. Sills
Plus aucun poste en cours
Health Technology
Profil
Kevin H.
Sills is a Director of Oragenics, Inc. and Vice President of Pharmaceutical Development for King Pharmaceuticals Research & Development.
He was a Faculty Member at the Center for Professional Advancement, President of NC Pharmaceutical Discussion Group, and a Member of the Licensing Executives Society and the American Assoc of Pharmaceutical Scientists.
Mr. Sills has 25 years of experience in pharmaceutical R&D activities.
He received a BS degree in Biology and Medial Technology from the University of North Carolina.
Anciens postes connus de Kevin H. Sills
| Sociétés | Poste | Fin |
|---|---|---|
| ORAGENICS, INC. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Oragenics, Inc.
 Oragenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics and treatments against infectious disease and oral mucositis | Health Technology |
